Published :
Tables : 55
Figures : 49
Category : Healthcare
No. of Pages : 240
Report Code : HC-U3917
Pharmacovigilance Market is poised to value over CAGR of over 11.5% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmacovigilance Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Pharmacovigilance Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Pharmacovigilance Market: • Accenture • Clinquest Group B.V. • IQVIA • Cognizant • Laboratory Corporation of America Holdings • IBM Corporation • ArisGlobal • ICON Plc. • Capgemini • ITClinical • TAKE Solutions • PAREXEL International Corporation • BioClinica, Inc. • Wipro Limited • UNITED BIOSOURCE CORPORATION • FMD K&L (Note: The list of the major players will be updated with the latest market scenario and trends) Pharmacovigilance Market Segmentation: By Service Provider • In-house • Contract Outsourcing By Product Life Cycle • Pre-clinical • Phase I • Phase II • Phase III • Phase IV By Type • Spontaneous Reporting • Intensified ADR Reporting • Targeted Spontaneous Reporting • Cohort Event Monitoring • EHR Mining By Process Flow • Case Data Management o Case Logging o Case Data Analysis o Medical Reviewing & Reporting • Signal Detection o Adverse Event Logging o Adverse Event Analysis o Adverse Event Review & Reporting • Risk Management System o Risk Evaluation System o Risk Mitigation System By Therapeutic Area • Oncology • Neurology • Cardiology • Respiratory Systems • Others By End-Users • Pharmaceuticals • Biotechnology Companies • Medical Device Manufacturers • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Pharmacovigilance Market By Service Provider, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Users and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Product Type launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmacovigilance Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Pharmacovigilance Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Pharmacovigilance Market: • Accenture • Clinquest Group B.V. • IQVIA • Cognizant • Laboratory Corporation of America Holdings • IBM Corporation • ArisGlobal • ICON Plc. • Capgemini • ITClinical • TAKE Solutions • PAREXEL International Corporation • BioClinica, Inc. • Wipro Limited • UNITED BIOSOURCE CORPORATION • FMD K&L (Note: The list of the major players will be updated with the latest market scenario and trends) Pharmacovigilance Market Segmentation:
By Service Provider • In-house • Contract Outsourcing
By Product Life Cycle • Pre-clinical • Phase I • Phase II • Phase III • Phase IV
By Type • Spontaneous Reporting • Intensified ADR Reporting • Targeted Spontaneous Reporting • Cohort Event Monitoring • EHR Mining
By Process Flow • Case Data Management o Case Logging o Case Data Analysis o Medical Reviewing & Reporting • Signal Detection o Adverse Event Logging o Adverse Event Analysis o Adverse Event Review & Reporting • Risk Management System o Risk Evaluation System o Risk Mitigation System
By Therapeutic Area • Oncology • Neurology • Cardiology • Respiratory Systems • Others
By End-Users • Pharmaceuticals • Biotechnology Companies • Medical Device Manufacturers • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Pharmacovigilance Market By Service Provider, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Users and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Product Type launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Pharmacovigilance Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Pharmacovigilance Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Pharmacovigilance Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Pharmacovigilance Market, By Service Provider Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. In-house 7.2. Contract Outsourcing 8. Global Pharmacovigilance Market, By Product Life Cycle Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Pre-clinical 8.2. Phase I 8.3. Phase II 8.4. Phase III 8.5. Phase IV 9. Global Pharmacovigilance Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Spontaneous Reporting 9.2. Intensified ADR Reporting 9.3. Targeted Spontaneous Reporting 9.4. Cohort Event Monitoring 9.5. EHR Mining 10.Global Pharmacovigilance Market, By Process Flow Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Case Data Management 10.1.1. Case Logging 10.1.2. Case Data Analysis 10.1.3. Medical Reviewing & Reporting 10.2. Signal Detection 10.2.1. Adverse Event Logging 10.2.2. Adverse Event Analysis 10.2.3. Adverse Event Review & Reporting 10.3. Risk Management System 10.3.1. Risk Evaluation System 10.3.2. Risk Mitigation System 11. Global Pharmacovigilance Market, By Therapeutic Area Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Oncology 11.2. Neurology 11.3. Cardiology 11.4. Respiratory Systems 11.5. Others 12. Global Pharmacovigilance Market, By End-Users Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Pharmaceuticals 12.2. Biotechnology Companies 12.3. Medical Device Manufacturers 12.4. Others 13. North America Pharmacovigilance Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. U.S.A 13.2.2. Canada 13.2.3. Mexico 13.3. Market Size (USD Million) Forecast for North America 2022-2028 14. Latin America Pharmacovigilance Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Brazil 14.2.2. Venezuela 14.2.3. Argentina 14.2.4. Rest of Latin America 14.3. Market Size (USD Million) Forecast for Latin America 2022-2028 15. Europe Pharmacovigilance Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Germany 15.2.2. U.K 15.2.3. France 15.2.4. Italy 15.2.5. Spain 15.2.6. Russia 15.2.7. Poland 15.2.8. Rest of Europe 15.3. Market Size (USD Million) Forecast for Europe 2022-2028 16. Asia Pacific Pharmacovigilance Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Japan 16.2.2. China 16.2.3. India 16.2.4. Australia and New Zealand 16.2.5. ASEAN 16.2.6. Rest of Asia Pacific 16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 17. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. GCC 17.2.2. Israel 17.2.3. South Africa 17.2.4. Rest of MEA 17.3. Market Size (USD Million) Forecast for MEA 2022-2028 18. Market Share Analysis and Competitive Landscape 18.1. Global Landscape - Key Players, Revenue and Presence 18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 18.3. Global Emerging Companies 18.4. North America - Market Share Analysis and Key Regional Players 18.5. Europe - Market Share Analysis and Key Regional Players 18.6. Asia Pacific - Market Share Analysis and Key Regional Players 18.7. Global Key Player - Growth Matrix 19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 19.1. Accenture 19.1.1. Company Overview 19.1.2. Product Portfolio 19.1.3. SWOT Analysis 19.1.4. Financial Overview 19.1.5. Strategic Overview 19.2. Clinquest Group B.V. 19.2.1. Company Overview 19.2.2. Product Portfolio 19.2.3. SWOT Analysis 19.2.4. Financial Overview 19.2.5. Strategic Overview 19.3. IQVIA 19.3.1. Company Overview 19.3.2. Product Portfolio 19.3.3. SWOT Analysis 19.3.4. Financial Overview 19.3.5. Strategic Overview 19.4. Cognizant 19.4.1. Company Overview 19.4.2. Product Portfolio 19.4.3. SWOT Analysis 19.4.4. Financial Overview 19.4.5. Strategic Overview 19.5. Laboratory Corporation of America Holdings 19.5.1. Company Overview 19.5.2. Product Portfolio 19.5.3. SWOT Analysis 19.5.4. Financial Overview 19.5.5. Strategic Overview 19.6. IBM Corporation 19.6.1. Company Overview 19.6.2. Product Portfolio 19.6.3. SWOT Analysis 19.6.4. Financial Overview 19.6.5. Strategic Overview 19.7. ArisGlobal 19.7.1. Company Overview 19.7.2. Product Portfolio 19.7.3. SWOT Analysis 19.7.4. Financial Overview 19.7.5. Strategic Overview 19.8. ICON Plc. 19.8.1. Company Overview 19.8.2. Product Portfolio 19.8.3. SWOT Analysis 19.8.4. Financial Overview 19.8.5. Strategic Overview 19.9. Capgemini 19.9.1. Company Overview 19.9.2. Product Portfolio 19.9.3. SWOT Analysis 19.9.4. Financial Overview 19.9.5. Strategic Overview 19.10.ITClinical 19.10.1. Company Overview 19.10.2. Product Portfolio 19.10.3. SWOT Analysis 19.10.4. Financial Overview 19.10.5. Strategic Overview 19.11.TAKE Solutions 19.11.1. Company Overview 19.11.2. Product Portfolio 19.11.3. SWOT Analysis 19.11.4. Financial Overview 19.11.5. Strategic Overview 19.12.PAREXEL International Corporation 19.12.1. Company Overview 19.12.2. Product Portfolio 19.12.3. SWOT Analysis 19.12.4. Financial Overview 19.12.5. Strategic Overview 19.13.BioClinica, Inc. 19.13.1. Company Overview 19.13.2. Product Portfolio 19.13.3. SWOT Analysis 19.13.4. Financial Overview 19.13.5. Strategic Overview 19.14.Wipro Limited 19.14.1. Company Overview 19.14.2. Product Portfolio 19.14.3. SWOT Analysis 19.14.4. Financial Overview 19.14.5. Strategic Overview 19.15.UNITED BIOSOURCE CORPORATION 19.15.1. Company Overview 19.15.2. Product Portfolio 19.15.3. SWOT Analysis 19.15.4. Financial Overview 19.15.5. Strategic Overview 19.16.FMD K&L 19.16.1. Company Overview 19.16.2. Product Portfolio 19.16.3. SWOT Analysis 19.16.4. Financial Overview 19.16.5. Strategic Overview 20. Pre and Post COVID-19 Impact 20.1. Positive influence on the healthcare industry 20.2. The financial disruption of the manufacturing sector 20.3. Impact of COVID-19 on emerging companies 20.4. Significant mandates in the healthcare regulations initiated by administrations 20.5. The overall economic slowdown of the developing and developed nations 21. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Pharmacovigilance Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Pharmacovigilance Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Pharmacovigilance Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Pharmacovigilance Market, By Service Provider Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. In-house 7.2. Contract Outsourcing
8. Global Pharmacovigilance Market, By Product Life Cycle Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Pre-clinical 8.2. Phase I 8.3. Phase II 8.4. Phase III 8.5. Phase IV
9. Global Pharmacovigilance Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Spontaneous Reporting 9.2. Intensified ADR Reporting 9.3. Targeted Spontaneous Reporting 9.4. Cohort Event Monitoring 9.5. EHR Mining
10.Global Pharmacovigilance Market, By Process Flow Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Case Data Management 10.1.1. Case Logging 10.1.2. Case Data Analysis 10.1.3. Medical Reviewing & Reporting 10.2. Signal Detection 10.2.1. Adverse Event Logging 10.2.2. Adverse Event Analysis 10.2.3. Adverse Event Review & Reporting 10.3. Risk Management System 10.3.1. Risk Evaluation System 10.3.2. Risk Mitigation System 11. Global Pharmacovigilance Market, By Therapeutic Area Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Oncology 11.2. Neurology 11.3. Cardiology 11.4. Respiratory Systems 11.5. Others
12. Global Pharmacovigilance Market, By End-Users Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Pharmaceuticals 12.2. Biotechnology Companies 12.3. Medical Device Manufacturers 12.4. Others
13. North America Pharmacovigilance Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. U.S.A 13.2.2. Canada 13.2.3. Mexico 13.3. Market Size (USD Million) Forecast for North America 2022-2028
14. Latin America Pharmacovigilance Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Brazil 14.2.2. Venezuela 14.2.3. Argentina 14.2.4. Rest of Latin America 14.3. Market Size (USD Million) Forecast for Latin America 2022-2028
15. Europe Pharmacovigilance Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Germany 15.2.2. U.K 15.2.3. France 15.2.4. Italy 15.2.5. Spain 15.2.6. Russia 15.2.7. Poland 15.2.8. Rest of Europe 15.3. Market Size (USD Million) Forecast for Europe 2022-2028
16. Asia Pacific Pharmacovigilance Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Japan 16.2.2. China 16.2.3. India 16.2.4. Australia and New Zealand 16.2.5. ASEAN 16.2.6. Rest of Asia Pacific 16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
17. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. GCC 17.2.2. Israel 17.2.3. South Africa 17.2.4. Rest of MEA 17.3. Market Size (USD Million) Forecast for MEA 2022-2028
18. Market Share Analysis and Competitive Landscape 18.1. Global Landscape - Key Players, Revenue and Presence 18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 18.3. Global Emerging Companies 18.4. North America - Market Share Analysis and Key Regional Players 18.5. Europe - Market Share Analysis and Key Regional Players 18.6. Asia Pacific - Market Share Analysis and Key Regional Players 18.7. Global Key Player - Growth Matrix
19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 19.1. Accenture 19.1.1. Company Overview 19.1.2. Product Portfolio 19.1.3. SWOT Analysis 19.1.4. Financial Overview 19.1.5. Strategic Overview 19.2. Clinquest Group B.V. 19.2.1. Company Overview 19.2.2. Product Portfolio 19.2.3. SWOT Analysis 19.2.4. Financial Overview 19.2.5. Strategic Overview 19.3. IQVIA 19.3.1. Company Overview 19.3.2. Product Portfolio 19.3.3. SWOT Analysis 19.3.4. Financial Overview 19.3.5. Strategic Overview 19.4. Cognizant 19.4.1. Company Overview 19.4.2. Product Portfolio 19.4.3. SWOT Analysis 19.4.4. Financial Overview 19.4.5. Strategic Overview 19.5. Laboratory Corporation of America Holdings 19.5.1. Company Overview 19.5.2. Product Portfolio 19.5.3. SWOT Analysis 19.5.4. Financial Overview 19.5.5. Strategic Overview 19.6. IBM Corporation 19.6.1. Company Overview 19.6.2. Product Portfolio 19.6.3. SWOT Analysis 19.6.4. Financial Overview 19.6.5. Strategic Overview 19.7. ArisGlobal 19.7.1. Company Overview 19.7.2. Product Portfolio 19.7.3. SWOT Analysis 19.7.4. Financial Overview 19.7.5. Strategic Overview 19.8. ICON Plc. 19.8.1. Company Overview 19.8.2. Product Portfolio 19.8.3. SWOT Analysis 19.8.4. Financial Overview 19.8.5. Strategic Overview 19.9. Capgemini 19.9.1. Company Overview 19.9.2. Product Portfolio 19.9.3. SWOT Analysis 19.9.4. Financial Overview 19.9.5. Strategic Overview 19.10.ITClinical 19.10.1. Company Overview 19.10.2. Product Portfolio 19.10.3. SWOT Analysis 19.10.4. Financial Overview 19.10.5. Strategic Overview 19.11.TAKE Solutions 19.11.1. Company Overview 19.11.2. Product Portfolio 19.11.3. SWOT Analysis 19.11.4. Financial Overview 19.11.5. Strategic Overview 19.12.PAREXEL International Corporation 19.12.1. Company Overview 19.12.2. Product Portfolio 19.12.3. SWOT Analysis 19.12.4. Financial Overview 19.12.5. Strategic Overview 19.13.BioClinica, Inc. 19.13.1. Company Overview 19.13.2. Product Portfolio 19.13.3. SWOT Analysis 19.13.4. Financial Overview 19.13.5. Strategic Overview 19.14.Wipro Limited 19.14.1. Company Overview 19.14.2. Product Portfolio 19.14.3. SWOT Analysis 19.14.4. Financial Overview 19.14.5. Strategic Overview 19.15.UNITED BIOSOURCE CORPORATION 19.15.1. Company Overview 19.15.2. Product Portfolio 19.15.3. SWOT Analysis 19.15.4. Financial Overview 19.15.5. Strategic Overview 19.16.FMD K&L 19.16.1. Company Overview 19.16.2. Product Portfolio 19.16.3. SWOT Analysis 19.16.4. Financial Overview 19.16.5. Strategic Overview
20. Pre and Post COVID-19 Impact 20.1. Positive influence on the healthcare industry 20.2. The financial disruption of the manufacturing sector 20.3. Impact of COVID-19 on emerging companies 20.4. Significant mandates in the healthcare regulations initiated by administrations 20.5. The overall economic slowdown of the developing and developed nations
21. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics